Reduction of radiation pneumonitis by V20-constraints in breast cancer

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Goldman, Ulla B ^a,c   Wennberg, Berit ^a   Svane, Gunilla ^a   Bylund, Håkan ^b   Lind, Pehr ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; RADIATION PNEUMONIA; THORAX RADIOGRAPHY; BREAST TUMOR; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; LUNG; RADIATION DOSE; RADIATION EXPOSURE; RADIOGRAPHY;

BREAST NEOPLASMS; FEMALE; HUMANS; LUNG; QUALITY OF LIFE; RADIATION DOSAGE; RADIATION PNEUMONITIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 79952116371     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-99     Document Type: Article

References (28)

1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
2. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997, 337:949-955. 10.1056/NEJM199710023371401, 9395428.
3. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999, 353:1641-1648. 10.1016/S0140-6736(98)09201-0, 10335782.
4. Herrman T, Schorcht J, V M. Late sequelae in oncology. Berlin 1995, Dunst J, Saueer R.
5. Lind PA, Svane G, Gagliardi G, Svensson C. Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999, 43:489-496.
6. Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, Prosnitz LR. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer 2002, 94:2821-2829. 10.1002/cncr.10573, 12115368.
7. Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, Roche M, Powell SN. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001, 93:1806-1811. 10.1093/jnci/93.23.1806, 11734597.
8. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996, 88:918-922. 10.1093/jnci/88.13.918, 8656444.
9. Lind PA, Bylund H, Wennberg B, Svensson C, Svane G. Abnormalities on chest radiographs following radiation therapy for breast cancer. Eur Radiol 2000, 10:484-489. 10.1007/s003300050081, 10757001.
10. Baumann M. Impact of endogenous and exogenous factors on radiation sequelae 1995, Berlin: Springer-Verlag.
11. Ho AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA, Green S, Haffty B, Drumea K, Leitzin L, et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys 2006, 65:646-655.
12. Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, Sozzi WJ, Zouhair A, Mirimanoff RO, Azria D. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 2005, 11:7426-7433. 10.1158/1078-0432.CCR-04-2634, 16243816.
13. Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, Mornex F, Pelegrin A, Dubois JB, Mirimanoff RO, Rosenstein BS. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 2008, 14:6284-6288. 10.1158/1078-0432.CCR-08-0700, 2771757, 18829510.
14. Bjermer L, Franzen L, Littbrand B, Nilsson K, Angstrom T, Henriksson R. Effects of smoking and irradiated volume on inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. Cancer Res 1990, 50:2027-2030.
15. Davis SD, Yankelevitz DF, Henschke CI. Radiation effects on the lung: clinical features, pathology, and imaging findings. AJR Am J Roentgenol 1992, 159:1157-1164.
16. Slanina J, Sigmund G, Hinkelbein W, Wenz W, Wannenmacher M. [Pulmonary reaction to radiation following mantle-field irradiation. Comparison of follow-up by conventional x-ray and by computed tomography]. Radiologe 1988, 28:20-28.
17. Lind P. Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation. Acta Oncol 2006, 45:13-15. 10.1080/02841860500466632, 16464790.
18. Lind PA, Rosfors S, Wennberg B, Glas U, Bevegard S, Fornander T. Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother Oncol 1998, 49:245-254. 10.1016/S0167-8140(98)00121-2, 10075257.
19. Arriagada R, de Guevara JC, Mouriesse H, Hanzen C, Couanet D, Ruffie P, Baldeyrou P, Dewar J, Lusinchi A, Martin M, et al. Limited small cell lung cancer treated by combined radiotherapy and chemotherapy: evaluation of a grading system of lung fibrosis. Radiother Oncol 1989, 14:1-8. 10.1016/0167-8140(89)90002-9, 2538863.
20. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376. 10.1093/jnci/85.5.365, 8433390.
21. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996, 14:2756-2768.
22. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16:139-144.
23. Velikova G, Stark D, Selby P. Quality of life instruments in oncology. Eur J Cancer 1999, 35:1571-1580. 10.1016/S0959-8049(99)00193-8, 10673964.
24. Lind PA, Wennberg B, Gagliardi G, Rosfors S, Blom-Goldman U, Lidestahl A, Svane G. ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys 2006, 64:765-770.
25. Lind PA, Wennberg B, Gagliardi G, Fornander T. Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat 2001, 68:199-210. 10.1023/A:1012292019599, 11727957.
26. Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K, Moscardo CL, Lemanski C, Coelho M, Rosenstein B, et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol 2010, 11:258-265. 10.1016/S1470-2045(10)70013-9, 20138810.
27. Recht A. Radiotherapy, antihormonal therapy, and personalised medicine. Lancet Oncol 2010, 11:215-216. 10.1016/S1470-2045(10)70037-1, 20138808.
28. Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, Tennis M, Czene K. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol 2005, 23:7467-7474. 10.1200/JCO.2005.01.7335, 16234513.